GHG Protocol for Healthcare

What is GHG Protocol?

The Greenhouse Gas (GHG) Protocol is the world's most widely used accounting and reporting standard for greenhouse gas emissions, developed by the World Resources Institute (WRI) and the World Business Council for Sustainable Development (WBCSD). It provides organizations across all sectors with a comprehensive framework to measure, manage, and report their carbon footprint in a consistent and credible manner. Since its introduction in 2001, the GHG Protocol has become the foundational reference for corporate climate action, informing national policies, investment decisions, and sustainability strategies globally.

GHG Protocol and the Healthcare Industry

The healthcare sector is one of the most energy-intensive and resource-heavy industries in the global economy. Hospitals operate around the clock, consuming vast quantities of electricity, natural gas, and water while generating significant volumes of medical waste, pharmaceutical byproducts, and single-use plastics. According to research published in the journal Health Affairs, the US healthcare system alone accounts for approximately 8.5 percent of national greenhouse gas emissions, a figure that mirrors patterns seen in other developed economies.

The GHG Protocol directly affects healthcare organizations because it establishes the methodology by which they must identify, quantify, and disclose their climate impact. Hospitals and health systems are increasingly required by investors, regulators, and procurement partners to report emissions according to internationally recognized standards. The European Corporate Sustainability Reporting Directive (CSRD), for example, mandates that large healthcare companies operating in the EU align their disclosures with GHG Protocol categories.

Concrete examples of healthcare-specific emission sources include the use of inhaled anesthetic gases such as desflurane, which has a global warming potential thousands of times greater than carbon dioxide; the long-distance cold-chain logistics required for vaccine and pharmaceutical distribution; the energy consumed by MRI machines and surgical theaters operating continuously; and the fleet emissions from patient transport and ambulance services. Each of these sources falls within a defined GHG Protocol scope and must be accounted for systematically.

Key Requirements

• Scope 1 Emissions Inventory: Healthcare organizations must measure all direct greenhouse gas emissions from sources they own or control, including on-site combustion in boilers and furnaces, emissions from owned vehicle fleets, fugitive refrigerant leaks from medical cooling equipment, and nitrous oxide and other anesthetic gases released during patient care procedures.
• Scope 2 Emissions Accounting: Facilities must report indirect emissions associated with the purchase of electricity, steam, heating, and cooling. Hospitals with large campuses and 24-hour energy demands must track consumption by building, department, or cost center to enable accurate attribution and reduction planning.
• Scope 3 Value Chain Reporting: This category, while voluntary under older frameworks but increasingly mandatory under emerging regulation, requires organizations to account for emissions across their entire value chain. For healthcare companies, this includes pharmaceutical and medical device procurement, business travel by clinical and administrative staff, patient commuting to facilities, waste disposal, and downstream use of sold products such as medications or medical devices.
• Organizational Boundary Setting: Companies must define the boundaries of their reporting entity using either an equity share or control approach, which is particularly important for healthcare networks that include subsidiary clinics, joint-venture surgical centers, or franchised care facilities.
• Activity Data Collection: Accurate reporting depends on collecting granular operational data including energy bills, fuel purchase records, refrigerant top-up logs, fleet mileage reports, waste disposal manifests, and procurement spend data from supplier contracts.
• Emissions Factor Application: Organizations must apply appropriate and up-to-date emissions factors, sourcing region-specific electricity grid factors from national authorities and using IPCC-recommended global warming potential values for gases such as methane, nitrous oxide, and hydrofluorocarbons.
• Third-Party Verification: For publicly disclosed reports or those submitted to regulatory bodies, the GHG Protocol recommends independent assurance by an accredited verifier to ensure completeness, consistency, and accuracy of reported data.
• Science-Based Target Alignment: Many healthcare organizations are expected to set emissions reduction targets aligned with the Science Based Targets initiative (SBTi), which uses GHG Protocol methodology as its accounting foundation.

Implementation Steps for Healthcare Companies

1. Establish governance and assign ownership. Designate a sustainability lead or cross-functional working group that includes representatives from finance, facilities management, procurement, and clinical operations. Without clear ownership, data collection stalls and reporting timelines slip. In large hospital networks, this may involve appointing site-level sustainability coordinators who report to a central environmental team.
2. Define the organizational and operational boundary. Determine which legal entities, facilities, and operational activities fall within the reporting boundary. A healthcare holding company with owned hospitals, leased clinics, and minority-stake diagnostic centers must decide which sites are included and which approach, equity share or operational control, best reflects the organization's actual influence over emissions.
3. Conduct a baseline emissions assessment. Perform an initial GHG inventory covering Scope 1, Scope 2, and at minimum the most material Scope 3 categories. For most healthcare providers, the highest-priority Scope 3 categories are purchased goods and services (pharmaceuticals and medical supplies), upstream transportation and distribution, and waste generated in operations. Use the baseline year as a reference point against which all future reductions are measured.
4. Build a data collection infrastructure. Integrate emissions data collection into existing procurement, finance, and facilities management systems. Implement automated meter readings for electricity and gas, establish protocols for logging refrigerant purchases and leaks, and work with your supply chain team to obtain emissions data or spend-based proxies from key vendors, including pharmaceutical manufacturers and medical device suppliers.
5. Calculate and verify emissions. Apply the relevant emissions factors to collected activity data using a recognized calculation tool or purpose-built carbon accounting software. Review results for anomalies, cross-check against previous periods or benchmarks from comparable facilities, and where material discrepancies arise, investigate data quality before finalizing figures.
6. Set reduction targets and build a decarbonization roadmap. Identify the highest-impact emission reduction opportunities specific to your operations. Common interventions in healthcare include switching from desflurane to lower-impact anesthetic agents such as sevoflurane, installing LED lighting and building energy management systems, transitioning owned fleets to electric vehicles, and engaging with pharmaceutical suppliers on their own decarbonization plans. Commit to measurable annual targets aligned with a 1.5 degree Celsius pathway where feasible.
7. Report publicly and engage stakeholders. Publish your GHG emissions data through an annual sustainability or ESG report, and consider submitting to the CDP (formerly Carbon Disclosure Project) to benchmark performance against healthcare peers. Share progress with clinical staff, patients, and procurement partners to build organizational momentum and demonstrate accountability.
8. Review, improve, and recalculate annually. As your data collection matures and your organizational boundary evolves, restate prior year figures to maintain comparability. Incorporate lessons learned from each reporting cycle, address gaps in Scope 3 coverage, and update emissions factors to reflect the latest grid or IPCC data.

Frequently Asked Questions

Do small and mid-sized healthcare providers need to comply with the GHG Protocol?

The GHG Protocol itself is a voluntary accounting standard rather than a legally binding regulation, meaning no organization is directly compelled to follow it by the protocol alone. However, regulatory frameworks that do carry legal weight, such as the EU's CSRD and the US SEC's climate disclosure rules, explicitly reference GHG Protocol methodology. Healthcare providers that meet the revenue or employee thresholds defined in these regulations are therefore effectively required to follow GHG Protocol principles as part of their compliance obligations. Even smaller providers may face indirect pressure through public procurement requirements or NHS Supply Chain sustainability criteria in the UK, which increasingly require suppliers to demonstrate GHG-compliant reporting.

Which GHG Protocol scope is most challenging for healthcare organizations?

Scope 3 consistently presents the greatest challenge for healthcare organizations due to the complexity and opacity of the healthcare supply chain. Pharmaceutical manufacturing, for example, is highly emissions-intensive, involving energy-heavy chemical synthesis, solvent use, and temperature-controlled logistics, yet suppliers rarely disclose product-level carbon data. Similarly, quantifying patient and visitor travel or the end-of-life emissions from single-use medical devices requires estimation methodologies and assumptions that introduce uncertainty into reported figures. Organizations typically begin with Scope 1 and Scope 2 before progressively expanding Scope 3 coverage over two to three reporting cycles.

How should a hospital account for medical gases such as nitrous oxide and desflurane?

Medical gases used in clinical care are classified as Scope 1 fugitive emissions under the GHG Protocol. Hospitals must track the quantity of each gas purchased and estimate the proportion that escapes into the atmosphere during administration. Desflurane has a 100-year global warming potential of approximately 2,540 times that of carbon dioxide, making even small volumes highly material to a facility's overall carbon footprint. Many healthcare systems have begun eliminating desflurane from formularies entirely, both as a climate measure and as a cost reduction strategy, since volatile anesthetic agents are among the most expensive consumables in anesthesia departments.

Can the GHG Protocol help healthcare companies reduce costs as well as emissions?

Yes. The data visibility that GHG Protocol implementation requires often surfaces significant energy inefficiencies and procurement patterns that drive cost as well as emissions. Hospitals that complete a rigorous Scope 1 and Scope 2 inventory frequently identify poorly insulated buildings, inefficient legacy equipment, and lighting systems that represent straightforward energy reduction opportunities. Scope 3 analysis of pharmaceutical procurement sometimes reveals opportunities to consolidate suppliers or switch to biosimilar medications with lower manufacturing carbon footprints, which also carry lower price tags. Sustainability investments in healthcare, such as on-site solar generation or heat pump systems, commonly deliver return on investment within five to eight years while permanently reducing both carbon exposure and energy cost volatility.

Summary

The GHG Protocol provides healthcare organizations with a rigorous, internationally recognized framework to understand and systematically reduce their contribution to climate change, addressing everything from hospital energy consumption and medical gas emissions to the carbon footprint embedded in pharmaceutical supply chains. Implementing GHG Protocol reporting is no longer optional for healthcare providers seeking to meet evolving regulatory requirements, satisfy investor expectations, or demonstrate credible climate leadership to patients and communities. Organizations that begin their emissions inventory today will be better positioned to meet tightening disclosure mandates, reduce operational costs, and build the resilient, low-carbon healthcare systems that future generations will depend on.